New amido derivatives as potential BKCa potassium channel activators. XI

European Journal of Medicinal Chemistry

Volumn 43, Issue 4, 2008, Pages 792-799

  Calderone, Vincenzo ^a   Fiamingo, Francesca Lidia ^a   Amato, Gabriella ^a   Giorgi, Irene ^a   Livi, Oreste ^a   Martelli, Alma ^a   Martinotti, Enrica ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Amide; Benzanilide; BK potassium channel; BK activator

Indexed keywords

ANILIDE; BENZANILIDE DERIVATIVE; CARBENE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HYPERTENSION; MALE; NONHUMAN; POTASSIUM TRANSPORT; RAT; STRUCTURE ACTIVITY RELATION; VASOCONSTRICTION;

ANILIDES; ANIMALS; AORTA; ION CHANNEL GATING; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; VASODILATION; VASODILATOR AGENTS;

EID: 41449086803     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.06.005     Document Type: Article

References (24)

1. Calderone V. Curr. Med. Chem. 9 (2002) 1385-1395
2. Wu S.-N. Curr. Med. Chem. 10 (2003) 649-661
3. Ghatta S., Nimmagadda D., Xu X., and O'Rourke S. Pharmacol. Ther. 110 (2006) 103-116
4. Brayden J.E., and Nelson M.T. Science 256 (1992) 532-535
5. Tanaka Y., Koike K., and Toro L. J. Smooth Muscle Res. 4 and 5 (2004) 125-153
6. Biagi G., Giorgi I., Livi O., Scartoni V., Barili P.L., Calderone V., and Martinotti E. Farmaco 56 (2001) 827-834
7. Shintani Y., Node K., Asanuma H., Sanada S., Takashima S., Asano Y., Liao Y., Fujita M., Hirata A., Shinozaki Y., Fukushima T., Nagamachi Y., Okuda H., Kim J., Tomoike H., Hori M., and Kitakaze M. J. Mol. Cell. Cardiol. 37 (2004) 1213-1218
8. C-Cao M., Xia Q., Gao Q., Chen M., and Wong T.-M. J. Pharmacol. Exp. Ther. 312 (2005) 644-650
9. Sato T., Saito T., Saegusa N., and Nakaya H. Circulation 111 (2005) 198-203
10. Biagi G., Calderone V., Giorgi I., Livi O., Scartoni V., Baragatti B., and Martinotti E. Eur. J. Med. Chem. 35 (2000) 715-720
11. Baragatti B., Biagi G., Calderone V., Giorgi I., Livi O., Martinotti E., and Scartoni V. Eur. J. Med. Chem. 35 (2000) 949-955
12. Biagi G., Calderone V., Giorgi I., Livi O., Scartoni V., Baragatti B., and Martinotti E. Farmaco 56 (2001) 841-849
13. Olesen S.P., Munch E., Moldt P., and Drejer J. Eur. J. Pharmacol. 251 (1994) 53-59
14. Biagi G., Calderone V., Giorgi I., Livi O., Martinotti E., Martelli A., and Nardi A. Farmaco 59 (2004) 397-404
15. Calderone V., Giorgi I., Livi O., Martinotti E., Martelli A., and Nardi A. Farmaco 60 (2005) 367-375
16. Calderone V., Giorgi I., Livi O., Martinotti E., Mantuano E., Martelli A., and Nardi A. Eur. J. Med. Chem. 40 (2005) 521-528
17. Biagi G., Giorgi I., Livi O., Nardi A., Calderone V., Martelli A., Martinotti E., and LeRoy Salerni O. Eur. J. Med. Chem. 39 (2004) 491-498
18. Calderone V., Fiamingo F.L., Giorgi I., Leonardi M., Livi O., Martelli A., and Martinotti E. Eur. J. Med. Chem. 41 (2006) 761-767
19. Calderone V., Fiamingo F.L., Giorgi I., Leonardi M., Livi O., Martelli A., and Martinotti E. Eur. J. Med. Chem. 41 (2006) 1421-1429
20. Dean F.M., Goodchild J., Houghton L.E., Martin J.A., Morton R.B., Parton B., Price A.W., and Somvichien N. Tetrahedron Lett. 7 (1966) 4153-4159
21. Yamana T., Tsuji A., and Mizukami Y. Chem. Pharm. Bull. 21 (1973) 721-728
22. Agwada V.C. J. Chem. Eng. Data 27 (1982) 481-483
23. Burchat A.F., Chong J.M., and Nielsen N. J. Org. Chem. 61 (1996) 7627-7630
24. Waisser K., Perina M., Kunes J., Klimesova V., and Kaustova J. Farmaco 58 (2003) 1137-1149